MEI Pharma Inc. (MEIP) NASDAQ

$4 0.08 (2.04%)

Market Cap: $26.12M

As of 03/28/24 04:00 PM EDT. Market closed.

(MEIP)

MEI Pharma Inc. (MEIP)
NASDAQ

$4
0.08 (2.04%)

Market Cap: $26.12M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ?75 years of age ... read more

mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ?75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Daniel Gold
Full Time Employees
127
CEO Compensation (Base)
$592,250
CEO Compensation (Total)
$2.99M
URL
Address
11455 El Camino Real, Suite 250, California, San Diego, 92130.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Daniel Gold
Full Time Employees
127
CEO Compensation (Base)
$592,250
CEO Compensation (Total)
$2.99M
Address
11455 El Camino Real, Suite 250, California, San Diego, 92130.
PRICE CHART FOR MEI PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.96
Previous Close
$3.92
Days Range
$3.81 - $4.15
52 week range
$2.56 - $6.91
Volume
13,334
Avg. Volume (30 days)
27,071
Market Cap
$26.12M
Dividend Yield
-
P/E
1.32
Shares Outstanding
6,662,857
Open
$3.96
Previous Close
$3.92
Days Range
$3.81 - $4.15
52 week range
$2.56 - $6.91
Volume
13,334
Avg. Volume (30 days)
27,071
Market Cap
$26.12M
Dividend Yield
-
P/E
1.32
Shares Outstanding
6,662,857
FINANCIAL STATEMENTS FOR MEI PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MEI PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Funicular Funds, LP10% OwnerOct 20, 2023 Option Exercise$7.00120,600844,200611,440Oct 24, 2023, 07:34 PM
Anson Funds Management LP10% OwnerOct 20, 2023 Option Exercise$7.00179,0001,253,0001,093,188Oct 24, 2023, 07:32 PM
Funicular Funds, LP10% OwnerOct 11, 2023 Option Exercise$7.0030,000210,000490,840Oct 13, 2023, 05:04 PM
Anson Funds Management LP10% OwnerOct 11, 2023 Option Exercise$7.0050,000350,000914,188Oct 13, 2023, 05:02 PM
Anson Funds Management LP10% OwnerSep 22, 2023 Buy$6.8548,060329,331864,188Sep 25, 2023, 07:43 PM
Funicular Funds, LP10% OwnerSep 22, 2023 Buy$6.8532,040219,554460,840Sep 25, 2023, 07:41 PM
Anson Funds Management LP10% OwnerSep 21, 2023 Buy$6.4633,600217,110816,128Sep 22, 2023, 09:21 PM
Anson Funds Management LP10% OwnerSep 20, 2023 Buy$6.01120,000721,116782,528Sep 22, 2023, 09:21 PM
Funicular Funds, LP10% OwnerSep 20, 2023 Buy$6.0180,000480,744406,400Sep 22, 2023, 09:19 PM
Funicular Funds, LP10% OwnerSep 21, 2023 Buy$6.4622,400144,740428,800Sep 22, 2023, 09:19 PM
Baltic Charles V. IIIDirectorFeb 28, 2023 Buy$0.2281,50018,337105,750Mar 01, 2023, 05:16 PM
GHALIE RICHARD GChief Medical OfficerJul 05, 2022 Option Exercise$0.548,1964,42628,927Jul 07, 2022, 04:17 PM
Urso David MChief Operating Officer & GCJul 02, 2021 Option Exercise$2.9424,82572,98649,281Jul 06, 2021, 06:49 PM
GOLD DANIEL P PHDChief Executive OfficerJul 02, 2021 Option Exercise$2.9441,320121,481417,312Jul 06, 2021, 06:47 PM
GOLD DANIEL P PHDChief Executive OfficerMay 25, 2021 Option Exercise$2.525,00012,600458,632May 27, 2021, 01:35 PM
DRISCOLL FREDERICK WDirectorFeb 23, 2021 Sale$4.0325,000100,62537,500Feb 24, 2021, 12:08 PM
GOLD DANIEL P PHDChief Executive OfficerJul 23, 2020 Option Exercise$1.5712,00018,840453,632Jul 27, 2020, 01:59 PM
Reynolds Thomas CDirectorDec 19, 2019 Buy$1.6010,00016,00010,000Dec 20, 2019, 12:57 PM
DRISCOLL FREDERICK WDirectorDec 19, 2019 Buy$1.6062,500100,00062,500Dec 20, 2019, 12:56 PM
Drazba Brian G.Chief Financial OfficerDec 19, 2019 Buy$1.6012,50020,00037,500Dec 20, 2019, 12:55 PM
GOLD DANIEL P PHDChief Executive OfficerDec 19, 2019 Buy$1.6018,75030,000361,632Dec 20, 2019, 12:54 PM
GOLD DANIEL P PHDChief Executive OfficerSep 27, 2019 Option Exercise$1.5720,00031,400342,882Oct 01, 2019, 12:04 PM
White Christine AnnaDirectorSep 06, 2019 Buy$1.7415,00026,07415,000Sep 09, 2019, 04:52 PM
GOLD DANIEL P PHDChief Executive OfficerAug 06, 2018 Option Exercise$3.7550,938191,018322,882Sep 06, 2018, 08:20 PM
Urso David MChief Operating Officer & GCAug 06, 2018 Option Exercise$3.7517,76466,61533,606Aug 08, 2018, 06:01 PM
Urso David MChief Operating Officer & GCAug 07, 2018 Sale$3.589,50034,04424,106Aug 08, 2018, 06:01 PM
Mass Robert D.Chief Medical OfficerAug 06, 2018 Option Exercise$3.7517,70966,40933,661Aug 08, 2018, 06:00 PM
GOLD DANIEL P PHDChief Executive OfficerAug 06, 2018 Option Exercise$3.7554,093202,849319,727Aug 08, 2018, 05:59 PM
GOLD DANIEL P PHDChief Executive OfficerMar 29, 2018 Option Exercise$2.07128,920266,864271,080Mar 30, 2018, 02:14 PM
Baltic Charles V. IIIDirectorNov 27, 2017 Buy$2.2511,00024,80124,250Nov 29, 2017, 06:39 PM
Baltic Charles V. IIIDirectorNov 27, 2017 Sale$2.2111,00024,27213,250Nov 29, 2017, 06:39 PM
VIVO VENTURES VII, LLC10% OwnerNov 05, 2015 Sale$1.91225,660431,0113,328,017Nov 09, 2015, 08:09 PM
VIVO VENTURES VII, LLC10% OwnerNov 09, 2015 Sale$1.75157,352275,3663,163,105Nov 09, 2015, 08:09 PM
VIVO VENTURES VII, LLC10% OwnerNov 06, 2015 Sale$1.857,56013,9863,320,457Nov 09, 2015, 08:09 PM
Vivo Ventures V, LLC10% OwnerNov 09, 2015 Sale$1.759,14215,999183,767Nov 09, 2015, 08:09 PM
Vivo Ventures V, LLC10% OwnerNov 06, 2015 Sale$1.85440814192,909Nov 09, 2015, 08:09 PM
Vivo Ventures V, LLC10% OwnerNov 05, 2015 Sale$1.9113,11125,042193,349Nov 09, 2015, 08:09 PM
New Leaf Ventures II, L.P.10% OwnerMar 24, 2015 Sale$1.971,601,3903,160,1830Mar 26, 2015, 04:54 PM
VIVO VENTURES VII, LLC10% OwnerMar 24, 2015 Option Exercise$3.12455,1741,420,1433,553,677Mar 26, 2015, 03:02 PM
Vivo Ventures V, LLCMar 24, 2015 Option Exercise$3.1226,44582,508206,460Mar 26, 2015, 03:00 PM
Baltic Charles V. IIIDirectorJan 21, 2015 Buy$3.815,00019,05024,250Jan 23, 2015, 12:11 PM
Baltic Charles V. IIIDirectorDec 31, 2014 Buy$4.261,5006,3905,350Jan 02, 2015, 03:40 PM
Baltic Charles V. IIIDirectorDec 31, 2014 Buy$4.281,5006,42019,250Jan 02, 2015, 03:40 PM
New Leaf Ventures II, L.P.10% OwnerDec 09, 2014 Sale$6.0170,081421,0821,601,390Dec 10, 2014, 07:26 PM
New Leaf Ventures II, L.P.10% OwnerDec 08, 2014 Sale$6.059,00454,4951,671,471Dec 10, 2014, 07:26 PM
Baltic Charles V. IIIDirectorJun 30, 2014 Buy$6.609506,2703,850Jul 02, 2014, 11:57 AM
Baltic Charles V. IIIDirectorJun 30, 2014 Buy$6.521,0506,84617,750Jul 02, 2014, 11:57 AM
New Leaf Ventures II, L.P.10% OwnerNov 21, 2013 Sale$8.25365,0003,011,2501,680,475Nov 25, 2013, 05:34 PM
Vivo Ventures V, LLC10% OwnerOct 28, 2013 Sale$8.302,26318,790180,059Oct 29, 2013, 08:07 PM
Vivo Ventures V, LLC10% OwnerOct 25, 2013 Sale$8.2015,100123,820182,322Oct 29, 2013, 08:07 PM
Vivo Ventures V, LLC10% OwnerOct 29, 2013 Sale$8.2744364180,015Oct 29, 2013, 08:07 PM
VIVO VENTURES VII, LLC10% OwnerOct 29, 2013 Sale$8.277566,2523,098,503Oct 29, 2013, 08:05 PM
VIVO VENTURES VII, LLC10% OwnerOct 28, 2013 Sale$8.3038,953323,4353,099,259Oct 29, 2013, 08:05 PM
VIVO VENTURES VII, LLC10% OwnerOct 25, 2013 Sale$8.20259,9002,131,1803,138,212Oct 29, 2013, 08:05 PM
Vivo Ventures V, LLC10% OwnerOct 02, 2013 Sale$10.0028,243282,455197,422Oct 03, 2013, 07:30 PM
Vivo Ventures V, LLC10% OwnerOct 01, 2013 Sale$11.005,55161,046225,665Oct 03, 2013, 07:30 PM
VIVO VENTURES VII, LLC10% OwnerOct 02, 2013 Sale$10.00486,1074,861,5083,398,112Oct 03, 2013, 07:29 PM
VIVO VENTURES VII, LLC10% OwnerOct 01, 2013 Sale$11.0095,5391,050,6713,884,219Oct 03, 2013, 07:29 PM
Rueckert William DodgeDirectorMay 11, 2012 Option Exercise$5.342361,260654Sep 12, 2013, 08:00 PM
Baltic Charles V. IIIDirectorAug 16, 2013 Buy$6.821,2008,1842,900Aug 20, 2013, 04:37 PM
Baltic Charles V. IIIDirectorAug 16, 2013 Buy$6.821,4009,54816,700Aug 20, 2013, 04:37 PM
Baltic Charles V. IIIDirectorDec 21, 2012 Buy$7.171,70012,1831,700Aug 20, 2013, 03:13 PM
Baltic Charles V. IIIDirectorDec 21, 2012 Buy$7.191,80012,9404,300Aug 20, 2013, 03:13 PM
Baltic Charles V. IIIDirectorJan 24, 2013 Buy$6.258005,0005,100Aug 20, 2013, 02:57 PM
Baltic Charles V. IIIDirectorJan 25, 2013 Buy$6.0410,20061,63815,300Aug 20, 2013, 02:56 PM
Vivo Ventures V, LLC10% OwnerJun 28, 2013 Sale$7.584263,228231,216Jul 02, 2013, 07:30 PM
VIVO VENTURES VII, LLC10% OwnerJun 28, 2013 Sale$7.587,33755,5983,979,758Jul 02, 2013, 06:55 PM
VIVO VENTURES VII, LLC10% OwnerJun 11, 2013 Sale$7.80236,2731,842,9293,987,095Jun 13, 2013, 06:21 PM
Vivo Ventures V, LLC10% OwnerJun 11, 2013 Sale$7.8013,727107,071231,642Jun 13, 2013, 06:16 PM
Vivo Ventures V, LLC10% OwnerMay 16, 2013 Sale$9.071,0129,174245,369May 20, 2013, 06:32 PM
VIVO VENTURES VII, LLC10% OwnerMay 16, 2013 Sale$9.0717,428157,9944,223,368May 20, 2013, 06:21 PM
New Leaf Ventures II, L.P.10% OwnerMay 08, 2013 Sale$8.45100,000845,0002,045,475May 08, 2013, 05:26 PM
New Leaf Ventures II, L.P.10% OwnerMay 06, 2013 Sale$8.70100,000870,0002,145,475May 08, 2013, 05:26 PM
New Leaf Ventures II, L.P.10% OwnerApr 19, 2013 Sale$8.43157,3001,326,0392,245,475Apr 22, 2013, 05:39 PM
New Leaf Ventures II, L.P.10% OwnerApr 18, 2013 Sale$8.57100,000857,0002,402,775Apr 22, 2013, 05:39 PM
New Leaf Ventures II, L.P.10% OwnerFeb 19, 2013 Sale$6.80300,0002,040,0002,502,775Feb 20, 2013, 11:20 AM
New Leaf Ventures II, L.P.10% OwnerFeb 15, 2013 Sale$6.60197,2251,301,6852,802,775Feb 20, 2013, 11:20 AM
Baltic Charles V. IIIDirectorJan 25, 2013 Buy$6.0410,20061,63817,000Jan 29, 2013, 12:53 PM
Baltic Charles V. IIIDirectorJan 24, 2013 Buy$6.258005,0006,800Jan 28, 2013, 11:36 AM
Baltic Charles V. IIIDirectorDec 21, 2012 Buy$7.171,70012,1836,000Dec 26, 2012, 06:12 AM
Baltic Charles V. IIIDirectorDec 21, 2012 Buy$7.191,80012,9404,300Dec 26, 2012, 06:12 AM
Baltic Charles V. IIIDirectorJul 05, 2012 Buy$0.4315,0006,43115,000Jul 09, 2012, 02:39 PM
NOVOGEN LTD10% OwnerMay 11, 2012 Option Exercise$0.894,494,3773,999,99517,837,286May 15, 2012, 01:11 PM
Rueckert William DodgeDirectorMay 11, 2012 Option Exercise$0.891,4171,2613,501May 15, 2012, 01:10 PM
Williams BryanDirectorMay 11, 2012 Option Exercise$0.89250222750May 15, 2012, 01:09 PM
NOVOGEN LTD10% OwnerDec 29, 2011 Option Exercise$1.031,941,7471,999,99913,342,909Dec 30, 2011, 10:59 AM
NOVOGEN LTD10% OwnerSep 30, 2011 Option Exercise$1.501,333,3332,000,00011,401,162Oct 05, 2011, 03:16 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Funicular Funds, LP10% Owner10/20/2023844,200
Anson Funds Management LP10% Owner10/20/20231,253,000
Funicular Funds, LP10% Owner10/11/2023210,000
Anson Funds Management LP10% Owner10/11/2023350,000
Anson Funds Management LP10% Owner09/22/2023329,331
Funicular Funds, LP10% Owner09/22/2023219,554
Anson Funds Management LP10% Owner09/21/2023217,110
Anson Funds Management LP10% Owner09/20/2023721,116
Funicular Funds, LP10% Owner09/20/2023480,744
Funicular Funds, LP10% Owner09/21/2023144,740
Baltic Charles V. IIIDirector02/28/202318,337
GHALIE RICHARD GChief Medical Officer07/05/20224,426
Urso David MChief Operating Officer & GC07/02/202172,986
GOLD DANIEL P PHDChief Executive Officer07/02/2021121,481
GOLD DANIEL P PHDChief Executive Officer05/25/202112,600
DRISCOLL FREDERICK WDirector02/23/2021100,625
GOLD DANIEL P PHDChief Executive Officer07/23/202018,840
Reynolds Thomas CDirector12/19/201916,000
DRISCOLL FREDERICK WDirector12/19/2019100,000
Drazba Brian G.Chief Financial Officer12/19/201920,000
GOLD DANIEL P PHDChief Executive Officer12/19/201930,000
GOLD DANIEL P PHDChief Executive Officer09/27/201931,400
White Christine AnnaDirector09/06/201926,074
GOLD DANIEL P PHDChief Executive Officer08/06/2018191,018
Urso David MChief Operating Officer & GC08/06/201866,615
Urso David MChief Operating Officer & GC08/07/201834,044
Mass Robert D.Chief Medical Officer08/06/201866,409
GOLD DANIEL P PHDChief Executive Officer08/06/2018202,849
GOLD DANIEL P PHDChief Executive Officer03/29/2018266,864
Baltic Charles V. IIIDirector11/27/201724,801
Baltic Charles V. IIIDirector11/27/201724,272
VIVO VENTURES VII, LLC10% Owner11/05/2015431,011
VIVO VENTURES VII, LLC10% Owner11/09/2015275,366
VIVO VENTURES VII, LLC10% Owner11/06/201513,986
Vivo Ventures V, LLC10% Owner11/09/201515,999
Vivo Ventures V, LLC10% Owner11/06/2015814
Vivo Ventures V, LLC10% Owner11/05/201525,042
New Leaf Ventures II, L.P.10% Owner03/24/20153,160,183
VIVO VENTURES VII, LLC10% Owner03/24/20151,420,143
Vivo Ventures V, LLC03/24/201582,508
Baltic Charles V. IIIDirector01/21/201519,050
Baltic Charles V. IIIDirector12/31/20146,390
Baltic Charles V. IIIDirector12/31/20146,420
New Leaf Ventures II, L.P.10% Owner12/09/2014421,082
New Leaf Ventures II, L.P.10% Owner12/08/201454,495
Baltic Charles V. IIIDirector06/30/20146,270
Baltic Charles V. IIIDirector06/30/20146,846
New Leaf Ventures II, L.P.10% Owner11/21/20133,011,250
Vivo Ventures V, LLC10% Owner10/28/201318,790
Vivo Ventures V, LLC10% Owner10/25/2013123,820
Vivo Ventures V, LLC10% Owner10/29/2013364
VIVO VENTURES VII, LLC10% Owner10/29/20136,252
VIVO VENTURES VII, LLC10% Owner10/28/2013323,435
VIVO VENTURES VII, LLC10% Owner10/25/20132,131,180
Vivo Ventures V, LLC10% Owner10/02/2013282,455
Vivo Ventures V, LLC10% Owner10/01/201361,046
VIVO VENTURES VII, LLC10% Owner10/02/20134,861,508
VIVO VENTURES VII, LLC10% Owner10/01/20131,050,671
Rueckert William DodgeDirector05/11/20121,260
Baltic Charles V. IIIDirector08/16/20138,184
Baltic Charles V. IIIDirector08/16/20139,548
Baltic Charles V. IIIDirector12/21/201212,183
Baltic Charles V. IIIDirector12/21/201212,940
Baltic Charles V. IIIDirector01/24/20135,000
Baltic Charles V. IIIDirector01/25/201361,638
Vivo Ventures V, LLC10% Owner06/28/20133,228
VIVO VENTURES VII, LLC10% Owner06/28/201355,598
VIVO VENTURES VII, LLC10% Owner06/11/20131,842,929
Vivo Ventures V, LLC10% Owner06/11/2013107,071
Vivo Ventures V, LLC10% Owner05/16/20139,174
VIVO VENTURES VII, LLC10% Owner05/16/2013157,994
New Leaf Ventures II, L.P.10% Owner05/08/2013845,000
New Leaf Ventures II, L.P.10% Owner05/06/2013870,000
New Leaf Ventures II, L.P.10% Owner04/19/20131,326,039
New Leaf Ventures II, L.P.10% Owner04/18/2013857,000
New Leaf Ventures II, L.P.10% Owner02/19/20132,040,000
New Leaf Ventures II, L.P.10% Owner02/15/20131,301,685
Baltic Charles V. IIIDirector01/25/201361,638
Baltic Charles V. IIIDirector01/24/20135,000
Baltic Charles V. IIIDirector12/21/201212,183
Baltic Charles V. IIIDirector12/21/201212,940
Baltic Charles V. IIIDirector07/05/20126,431
NOVOGEN LTD10% Owner05/11/20123,999,995
Rueckert William DodgeDirector05/11/20121,261
Williams BryanDirector05/11/2012222
NOVOGEN LTD10% Owner12/29/20111,999,999
NOVOGEN LTD10% Owner09/30/20112,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN MEI PHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC150,8920.00135%4.61%Other
BLACKROCK INC.83,3180.00001%-0.25%Other
GEODE CAPITAL MANAGEMENT, LLC51,6160.00003%3.26%Other
CHANGE IN SHARES OUTSTANDING FOR MEI PHARMA INC
STOCK BUYBACKS FOR MEI PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0%
1Q
12/31/2023
06/30/2023
0%
2Q
12/31/2023
03/31/2023
0%
3Q
12/31/2023
12/31/2022
0%
4Q
12/31/2023
09/30/2022
0%
5Q
12/31/2023
06/30/2022
0.11%
6Q
12/31/2023
03/31/2022
0.15%
7Q
12/31/2023
12/31/2021
3.98%
8Q
12/31/2023
09/30/2021
16.98%
9Q
12/31/2023
06/30/2021
14.93%
10Q
12/31/2023
03/31/2021
18.39%
11Q
12/31/2023
12/31/2020
16.42%
12Q
12/31/2023
09/30/2020
15.92%
13Q
12/31/2023
06/30/2020
25.32%
14Q
12/31/2023
03/31/2020
25.72%
15Q
12/31/2023
12/31/2019
69.59%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0%
1Q
06/30/2023
0%
2Q
03/31/2023
0%
3Q
12/31/2022
0%
4Q
09/30/2022
0%
5Q
06/30/2022
0.11%
6Q
03/31/2022
0.15%
7Q
12/31/2021
3.98%
8Q
09/30/2021
16.98%
9Q
06/30/2021
14.93%
10Q
03/31/2021
18.39%
11Q
12/31/2020
16.42%
12Q
09/30/2020
15.92%
13Q
06/30/2020
25.32%
14Q
03/31/2020
25.72%
15Q
12/31/2019
69.59%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MEI PHARMA INC
LOADING...